Investing Profile

David Morris

Advisor
President, Head of Therapeutics and Technology at Valo Health
Berkeley, California
Photo of David Morris, Advisor

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Advisor
2
CompanyStageDateRound SizeTotal Raised
Soteria Biotherapeutics
Series AMay 2021$42M
$42M
Co-investors: David Allison (Westlake Village BioPartners)
Enterprise Therapeutics
Series BApr 2018$41M
$41M
Co-investors: Geert-Jan Mulder (Forbion), Alexander Mayweg (Versant Ventures)
Operating Partner Novartis Venture Fund2020 - 2021
Managing Director Novartis Venture Fund2018 - 2020